Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2015, Article ID 980310, 4 pages
http://dx.doi.org/10.1155/2015/980310
Research Article

Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?

1Department of Dermatology, Haseki Training and Research Hospital, 34080 Istanbul, Turkey
2Department of Dermatology, Mugla Sitki Kocman University Training and Research Hospital, 48000 Mugla, Turkey

Received 5 July 2015; Revised 20 October 2015; Accepted 22 October 2015

Academic Editor: Craig G. Burkhart

Copyright © 2015 Seyran Ozbas Gok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Paus, E. A. Olsen, and A. G. Messenger, “Hair growth disorders,” in Fitzpatrick’s Dermatology in General Medicine, K. Wolff, L. A. Goldsmith, S. I. Katz, B. A. Gilchrest, A. S. Paller, and D. J. Leffell, Eds., pp. 753–777, McGraw-Hill, New York, NY, USA, 7th edition, 2008. View at Google Scholar
  2. T. Fulop, D. Tessier, and A. Carpentier, “The metabolic syndrome,” Pathologie Biologie, vol. 54, no. 7, pp. 375–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Acibucu, M. Kayatas, and F. Candan, “The association of insulin resistance and metabolic syndrome in early androgenetic alopecia,” Singapore Medical Journal, vol. 51, no. 12, pp. 931–936, 2010. View at Google Scholar · View at Scopus
  4. C. Mumcuoglu, T. R. Ekmekci, and S. Ucak, “The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia,” European Journal of Dermatology, vol. 21, no. 1, pp. 79–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. N. S. A. Abdel Fattah and Y. W. Darwish, “Androgenetic alopecia and insulin resistance: are they truly associated?” International Journal of Dermatology, vol. 50, no. 4, pp. 417–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Matilainen, P. Koskela, and S. Keinänen-Kiukaanniemi, “Early androgenetic alopecia as a marker of insulin resistance,” The Lancet, vol. 356, no. 9236, pp. 1165–1166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Matilainen, M. Laakso, P. Hirsso, P. Koskela, U. Rajala, and S. Keinänen-Kiukaanniemi, “Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study,” Journal of Cardiovascular Risk, vol. 10, no. 3, pp. 227–231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Nabaie, S. Kavand, R. M. Robati et al., “Androgenic alopecia and insulin resistance: are they really related?” Clinical and Experimental Dermatology, vol. 34, no. 6, pp. 694–697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. E. A. Olsen, “Female pattern hair loss,” Journal of the American Academy of Dermatology, vol. 45, no. 3, supplement, pp. S70–S80, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. K. G. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar
  11. M. Arslan, “Metabolik sendrom: tanımı, patogenezi, tanı kriterleri ve bileşenleri,” Turkiye Klinikleri Journal of Internal Medical Sciences, vol. 2, no. 3, pp. 1–7, 2006. View at Google Scholar
  12. N. Trieu and G. D. Eslick, “Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis,” International Journal of Cardiology, vol. 176, no. 3, pp. 687–695, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-C. Yang, F.-N. Hsieh, L.-Y. Lin, C.-K. Hsu, H.-M. Sheu, and W. Chen, “Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study,” Journal of the American Academy of Dermatology, vol. 70, no. 2, pp. 297–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. E. J. Giltay, A. W. F. T. Toorians, A. R. Sarabjitsingh, N. A. de Vries, and L. J. G. Gooren, “Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals,” Journal of Endocrinology, vol. 180, no. 1, pp. 107–112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Pinkney, C. D. A. Stehouwer, S. W. Coppack, and J. S. Yudkin, “Endothelial dysfunction: cause of the insulin resistance syndrome,” Diabetes, vol. 46, no. 2, pp. 9–13, 1997. View at Google Scholar · View at Scopus
  16. S. M. Lesko, L. Rosenberg, and S. Shapiro, “A case-control study of baldness in relation to myocardial infarction in men,” The Journal of the American Medical Association, vol. 269, no. 8, pp. 998–1003, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ahouansou, P. Le Toumelin, B. Crickx, and V. Descamps, “Association of androgenetic alopecia and hypertension,” European Journal of Dermatology, vol. 17, no. 3, pp. 220–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Arias-Santiago, M. T. Gutiérrez-Salmerón, A. Buendía-Eisman, M. S. Girón-Prieto, and R. Naranjo-Sintes, “Hypertension and aldosterone levels in women with early-onset androgenetic alopecia,” British Journal of Dermatology, vol. 162, no. 4, pp. 786–789, 2010. View at Publisher · View at Google Scholar · View at Scopus